Makbule Ozlem Akbay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Makbule Ozlem Akbay has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Dilek Ernam
Department of Chest Diseases, University of Health Sciences, Istanbul Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, ISTANBUL, TÜRKİYE
3 shared publications Dilek Ernam
2 shared publications- Ozlem Sogukpinar
Clinic of Chest Diseases, İstanbul Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital, İstanbul, Türkiye
2 shared publications - Özlem Oruç
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL SÜREYYAPAŞA GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
2 shared publications - Ülkü Aka Aktürk
Clinic of Chest Diseases, İstanbul Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital, İstanbul, Türkiye
2 shared publications - Ahmet Emin Erbaycu
Department of Pulmonology, Cigli Training and Research Hospital, Izmir Bakırçay University, 35620 Izmir, Türkiye
1 shared publication
Latest Publications
- 25 December 2025
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 27 (3) , 378-385
THE PERFORMANCE OF HALP SCORE IN PREDICTING IN-HOSPITAL MORTALITY RISK AMONG VERY ELDERLY PATIENTS WITH RESPIRATORY-RELATED HOSPITALIZATION
Objective: This study aimed to investigate the performance of the novel score combining hemoglobin and albumin levels and lymphocyte and platelet count (HALP) in predicting in-hospital mortality risk in very elderly patients with respiratory-related hospitalization. Material and Methods: A total of 2011 very elderly (over 80 years) patients with respiratory-related hospitalization were included in this single-center retrospective cohort study. Reason for hospitalization, comorbidities, complete blood count and biochemistry findings on the first day of hospital admission, length of hospital stay (LOS), and in-hospital mortality were recorded. Factors predicting in-hospital mortality risk were analyzed via the univariate and multivariate Cox regression analyses. The ROC curve analysis was performed to determine the performance of HALP score in predicting the in-hospital mortality risk. Results: The median age was 83 years (range, 80 to 108 years) and males comprised 51.6% of the study population. The in-hospital mortality rate was 7%. The lower HALP score (HR 0.693, 95% CI: 0.549 to 0.875, p=0.002), male gender (HR 0.654, 95% CI: 0.453 to 0.945, p=0.024), and higher C-reactive protein (CRP) values (HR 1.004, 95% CI: 1.002 to 1.006, p
- 25 December 2025
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 27 (3) , 378-385
THE PERFORMANCE OF HALP SCORE IN PREDICTING IN-HOSPITAL MORTALITY RISK AMONG VERY ELDERLY PATIENTS WITH RESPIRATORY-RELATED HOSPITALIZATION
Objective: This study aimed to investigate the performance of the novel score combining hemoglobin and albumin levels and lymphocyte and platelet count (HALP) in predicting in-hospital mortality risk in very elderly patients with respiratory-related hospitalization. Material and Methods: A total of 2011 very elderly (over 80 years) patients with respiratory-related hospitalization were included in this single-center retrospective cohort study. Reason for hospitalization, comorbidities, complete blood count and biochemistry findings on the first day of hospital admission, length of hospital stay (LOS), and in-hospital mortality were recorded. Factors predicting in-hospital mortality risk were analyzed via the univariate and multivariate Cox regression analyses. The ROC curve analysis was performed to determine the performance of HALP score in predicting the in-hospital mortality risk. Results: The median age was 83 years (range, 80 to 108 years) and males comprised 51.6% of the study population. The in-hospital mortality rate was 7%. The lower HALP score (HR 0.693, 95% CI: 0.549 to 0.875, p=0.002), male gender (HR 0.654, 95% CI: 0.453 to 0.945, p=0.024), and higher C-reactive protein (CRP) values (HR 1.004, 95% CI: 1.002 to 1.006, p
- Open Access
- 19 February 2025
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 31, e947098
Hemoglobin-Albumin-Lymphocyte-Platelet Index and Risk of In-Hospital Mortality in 793 Adult Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
BACKGROUND Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory condition of the airways, recognized as a leading cause of morbidity and mortality worldwide. Acute exacerbations of COPD (AECOPD) significantly worsen clinical outcomes and often result in hospitalization, which is linked to increased mortality and a substantial socioeconomic burden. This study aimed to evaluate the role of the hemoglobin-albumin-lymphocyte-platelet (HALP) index in predicting the risk of in-hospital mortality in adult patients hospitalized for AECOPD. MATERIAL AND METHODS A total of 793 patients (mean±SD age: 71.5±10.2 years, range 23.8-98.4 years, 69.1% males) hospitalized with AECOPD were included in this retrospective cohort study. Data on patient demographics, comorbidities, laboratory findings on the day of hospital admission, intensive care unit (ICU) stay (on initial admission or over the course of hospitalization), and in-hospital mortality rates were recorded. The factors predicting in-hospital mortality risk were analyzed via multivariate logistic regression analysis. Receiver operating characteristic (ROC) curve analysis was performed to determine the performance of HALP score in identifying patients at risk of in-hospital mortality. RESULTS Multivariate logistic regression analysis revealed a significant association of lower HALP scores (OR 0.758, 95% CI: 0.586 to 0.980, P=0.034) with increased risk of in-hospital mortality. ROC curve analysis revealed the HALP score to identify patients at risk of in-hospital mortality at a cut-off value of <16.84 (area under curve [AUC]: 0.678, 95% CI: 0.615-0.742, P<0.001) with a sensitivity of 69.1%, specificity of 60.4%, and a NPV of 96.3%. CONCLUSIONS Our findings indicate that the HALP score (at a cut-off value of <16.84) can identify AECOPD patients at high risk of in-hospital mortality, emphasizing its potential use as a simple immune-nutritional prognostic biomarker in assisting accurate prognostic assessment and timely adjustment of treatment options in at-risk patients.
- 19 February 2025
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 31, e947098
Open AccessHemoglobin-Albumin-Lymphocyte-Platelet Index and Risk of In-Hospital Mortality in 793 Adult Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
BACKGROUND Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory condition of the airways, recognized as a leading cause of morbidity and mortality worldwide. Acute exacerbations of COPD (AECOPD) significantly worsen clinical outcomes and often result in hospitalization, which is linked to increased mortality and a substantial socioeconomic burden. This study aimed to evaluate the role of the hemoglobin-albumin-lymphocyte-platelet (HALP) index in predicting the risk of in-hospital mortality in adult patients hospitalized for AECOPD. MATERIAL AND METHODS A total of 793 patients (mean±SD age: 71.5±10.2 years, range 23.8-98.4 years, 69.1% males) hospitalized with AECOPD were included in this retrospective cohort study. Data on patient demographics, comorbidities, laboratory findings on the day of hospital admission, intensive care unit (ICU) stay (on initial admission or over the course of hospitalization), and in-hospital mortality rates were recorded. The factors predicting in-hospital mortality risk were analyzed via multivariate logistic regression analysis. Receiver operating characteristic (ROC) curve analysis was performed to determine the performance of HALP score in identifying patients at risk of in-hospital mortality. RESULTS Multivariate logistic regression analysis revealed a significant association of lower HALP scores (OR 0.758, 95% CI: 0.586 to 0.980, P=0.034) with increased risk of in-hospital mortality. ROC curve analysis revealed the HALP score to identify patients at risk of in-hospital mortality at a cut-off value of <16.84 (area under curve [AUC]: 0.678, 95% CI: 0.615-0.742, P<0.001) with a sensitivity of 69.1%, specificity of 60.4%, and a NPV of 96.3%. CONCLUSIONS Our findings indicate that the HALP score (at a cut-off value of <16.84) can identify AECOPD patients at high risk of in-hospital mortality, emphasizing its potential use as a simple immune-nutritional prognostic biomarker in assisting accurate prognostic assessment and timely adjustment of treatment options in at-risk patients.
- Open Access
- 1 January 2025
- Published by ScopeMed in Medicine Science | International Medical Journal
- Vol. 14 (2) , 521
The performance of prognostic nutritional index in predicting the respiratory-related hospitalization risk in bronchiectasis patients: A single-center retrospective cohort analysis
This study aimed to investigate the performance of prognostic nutritional index (PNI) to predict the respiratory-related hospitalization (RRH) risk over the course of a year in bronchiectasis patients. A total of 194 bronchiectasis patients were retrospectively evaluated in terms of chronic bacterial colonization and the bronchiectasis pattern, laboratory findings, FACED score and PNI on the day of presentation to the outpatient clinic in stable period, while patients were further followed up for RRH events over the course of a year. RRH was significantly more common in patients with vs. those without comorbid chronic obstructive pulmonary disease (75.7 vs. 35.8%, p<0.001) and previous tuberculosis history (70.0 vs. 44.4%, p=0.002). PNI values were significantly lower (46.9 vs. 55.9, p<0.001) in patients with vs. those without RRH. PNI was found to be a potential marker of hospitalization risk in bronchiectasis patients at a cut-off value of <50.55 (sensitivity: 90.5%, specificity: 69.7%) The decrease in PNI (OR, 0.782, 95% CI: 0.727-0.840, p<0.001) was found to independently predict the hospitalization risk. In conclusion, PNI seems to be a valuable marker in identifying the patients at risk of RRH, which can simply be calculated based on serum albumin level and peripheral lymphocyte count without needing clinical evaluation.
- 1 January 2025
- Published by ScopeMed in Medicine Science | International Medical Journal
- Vol. 14 (2) , 521
Open AccessThe performance of prognostic nutritional index in predicting the respiratory-related hospitalization risk in bronchiectasis patients: A single-center retrospective cohort analysis
This study aimed to investigate the performance of prognostic nutritional index (PNI) to predict the respiratory-related hospitalization (RRH) risk over the course of a year in bronchiectasis patients. A total of 194 bronchiectasis patients were retrospectively evaluated in terms of chronic bacterial colonization and the bronchiectasis pattern, laboratory findings, FACED score and PNI on the day of presentation to the outpatient clinic in stable period, while patients were further followed up for RRH events over the course of a year. RRH was significantly more common in patients with vs. those without comorbid chronic obstructive pulmonary disease (75.7 vs. 35.8%, p<0.001) and previous tuberculosis history (70.0 vs. 44.4%, p=0.002). PNI values were significantly lower (46.9 vs. 55.9, p<0.001) in patients with vs. those without RRH. PNI was found to be a potential marker of hospitalization risk in bronchiectasis patients at a cut-off value of <50.55 (sensitivity: 90.5%, specificity: 69.7%) The decrease in PNI (OR, 0.782, 95% CI: 0.727-0.840, p<0.001) was found to independently predict the hospitalization risk. In conclusion, PNI seems to be a valuable marker in identifying the patients at risk of RRH, which can simply be calculated based on serum albumin level and peripheral lymphocyte count without needing clinical evaluation.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (3) , e20231082
Diagnostic value of transthoracic needle biopsy in lung tumors
OBJECTIVE: Thoracic ultrasonography is widely used in imaging peripheral lesions and invasive interventional procedures. The aim of this study was to assess the diagnostic value of thoracic ultrasonography-guided transthoracic needle aspiration biopsy and the factors affecting the diagnosis of peripheral tumoral lung lesions.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (3) , e20231082
Open AccessDiagnostic value of transthoracic needle biopsy in lung tumors
OBJECTIVE: Thoracic ultrasonography is widely used in imaging peripheral lesions and invasive interventional procedures. The aim of this study was to assess the diagnostic value of thoracic ultrasonography-guided transthoracic needle aspiration biopsy and the factors affecting the diagnosis of peripheral tumoral lung lesions.
- 11 November 2023
- Published by Springer Nature
- p. 1025-1032
Vaccines and Hearing Loss
- Open Access
- 18 July 2023
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 29, e941425-e941425-10
Exploring the Impact of Positional Sleep Apnea in a Turkish Population: Unveiling the Untold Story
BACKGROUND The present study aimed to investigate the risk factors associated with demographical, clinical and polysomnographic features of positional sleep apnea through different criterion of positional sleep apnea (POSA vs e-POSA) in a large patient cohort from a tertiary referral center MATERIAL AND METHODS A total of 782 OSA patients who were further diagnosed with POSA (total: n=470, e-POSA: n=204) or non-POSA (n=312) based on apnea-hypopnea index (AHI) events by overnight polysomnography were included. Demographical, clinical, and polysomnographic characteristics were recorded, while independent predictors of POSA and e-POSA were determined via linear regression analysis. RESULTS Severe OSA (AHI ≥30/h) was less common in the POSA (33.4% vs 71.5%, P<0.001) and e-POSA (9.8% vs 62.3%, P<0.001) groups than in the non-POSA and non-e-POSA groups, respectively. For POSA and e-POSA, male sex (OR 2.195, P<0.001 and OR 2.021, P=0.004, respectively), low body mass index (BMI; OR 0.932, P<0.001 and OR 0.948, P=0.006), low AHI (OR 0.954 and OR 0.902, P<0.001 for each), and less desaturation (T90%, OR 0.972 and OR 0.968, P<0.001 for each) were the common statistically significant predictors. Younger age was an independent predictor of POSA (OR 0.97, P=0.003). POSA (median 20.4 s) and e-POSA (20.5 s) groups demonstrated similar apnea-hypopnea durations (min) as the non-POSA (median 21.1 s) group. CONCLUSIONS Our findings revealed that male sex and lower values of BMI, AHI, and desaturation were common determinants of POSA and e-POSA, while younger age independently predicted POSA. POSA and e-POSA had similar clinical and polysomnographic characteristics and shared the unvaried hypoxic burden.
- 18 July 2023
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 29, e941425-e941425-10
Open AccessExploring the Impact of Positional Sleep Apnea in a Turkish Population: Unveiling the Untold Story
BACKGROUND The present study aimed to investigate the risk factors associated with demographical, clinical and polysomnographic features of positional sleep apnea through different criterion of positional sleep apnea (POSA vs e-POSA) in a large patient cohort from a tertiary referral center MATERIAL AND METHODS A total of 782 OSA patients who were further diagnosed with POSA (total: n=470, e-POSA: n=204) or non-POSA (n=312) based on apnea-hypopnea index (AHI) events by overnight polysomnography were included. Demographical, clinical, and polysomnographic characteristics were recorded, while independent predictors of POSA and e-POSA were determined via linear regression analysis. RESULTS Severe OSA (AHI ≥30/h) was less common in the POSA (33.4% vs 71.5%, P<0.001) and e-POSA (9.8% vs 62.3%, P<0.001) groups than in the non-POSA and non-e-POSA groups, respectively. For POSA and e-POSA, male sex (OR 2.195, P<0.001 and OR 2.021, P=0.004, respectively), low body mass index (BMI; OR 0.932, P<0.001 and OR 0.948, P=0.006), low AHI (OR 0.954 and OR 0.902, P<0.001 for each), and less desaturation (T90%, OR 0.972 and OR 0.968, P<0.001 for each) were the common statistically significant predictors. Younger age was an independent predictor of POSA (OR 0.97, P=0.003). POSA (median 20.4 s) and e-POSA (20.5 s) groups demonstrated similar apnea-hypopnea durations (min) as the non-POSA (median 21.1 s) group. CONCLUSIONS Our findings revealed that male sex and lower values of BMI, AHI, and desaturation were common determinants of POSA and e-POSA, while younger age independently predicted POSA. POSA and e-POSA had similar clinical and polysomnographic characteristics and shared the unvaried hypoxic burden.
- Open Access
- 31 December 2022
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 24 (3) , 460-463
AKCİĞER KANSERLİ HASTALARIN ÖLÜM YERLERİ VE PALYATİF BAKIM
Amaç: Bu araştırmada, hastanemizde palyatif bakım servisi kurulduktan sonra akciğer kanseri nedeni ile ölen hastaların ölüm yerlerinin palyatif servise kaydığının gösterilmesi hedeflenmiştir. Gereç ve Yöntem: Çalışma 2017-2020 yılları arasında 4 yıllık retrospektif kesitsel çalışma olarak Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesinde yapıldı. Çalışma döneminde tanıları akciğer kanseri olan ve hastanede ölen hastalar çalışmaya alındı. Hastaların demografik verileri, yatış nedenleri, ek hastalıkları, hemogram, biyokimya değerleri, hastane içinde yer değişimleri, solunum destekleri (invaziv ve noninvaziv mekanik ventilasyon, oksijen) medikal tedavileri, ölüm yerleri, en çok dört ölüm nedenleri hastane mortalite verilerinden kayıt edildi. Veriler tanımlayıcı analiz ile özetlendi. Yıllar içindeki değişim kayıt edilen veriler ile karşılaştırıldı. Bulgular: Çalışma döneminde akciğer kanseri nedeni ile 15.552 hasta yatırıldı ve bu hastalardan ölen hasta sayısı 1896 (%12) olarak saptandı. Ölen 1896 hastanın 834’ü yani %44’ünün ilk yatış yeri palyatif bakımdı, bu hastalardan sadece 19’u tekrar yoğun bakıma sevk edildi. Palyatif servise yatışta yıllar içinde istatistiksel olarak anlamlı artış izlendi (p<0.001). Dış merkezlerden başvurunun seneler içinde istatistiksel olarak arttığı bulundu (p˂0.001). Hastalara uygulanan, non-invaziv mekanik ventilasyon, vazopressör tedavide yıllar içinde istatistiksel olarak anlamlı düşüş tespit edildi (p<0.001). Sonuç: Palyatif servislerin etkin olarak kullanıma başlanması yaşamın sonunda gereksiz agresif tedavilerin ve dolayısıyla maliyetin azalmasına ve yoğun bakım yataklarının etkin kullanımına da yol açacaktır. Ülke sağlık politikası belirlenmesine yardımcı olacak palyatif bakım farkındalığını arttırmaya yönelik çalışmalara ihtiyaç vardır.
- 31 December 2022
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 24 (3) , 460-463
Open AccessAKCİĞER KANSERLİ HASTALARIN ÖLÜM YERLERİ VE PALYATİF BAKIM
Amaç: Bu araştırmada, hastanemizde palyatif bakım servisi kurulduktan sonra akciğer kanseri nedeni ile ölen hastaların ölüm yerlerinin palyatif servise kaydığının gösterilmesi hedeflenmiştir. Gereç ve Yöntem: Çalışma 2017-2020 yılları arasında 4 yıllık retrospektif kesitsel çalışma olarak Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesinde yapıldı. Çalışma döneminde tanıları akciğer kanseri olan ve hastanede ölen hastalar çalışmaya alındı. Hastaların demografik verileri, yatış nedenleri, ek hastalıkları, hemogram, biyokimya değerleri, hastane içinde yer değişimleri, solunum destekleri (invaziv ve noninvaziv mekanik ventilasyon, oksijen) medikal tedavileri, ölüm yerleri, en çok dört ölüm nedenleri hastane mortalite verilerinden kayıt edildi. Veriler tanımlayıcı analiz ile özetlendi. Yıllar içindeki değişim kayıt edilen veriler ile karşılaştırıldı. Bulgular: Çalışma döneminde akciğer kanseri nedeni ile 15.552 hasta yatırıldı ve bu hastalardan ölen hasta sayısı 1896 (%12) olarak saptandı. Ölen 1896 hastanın 834’ü yani %44’ünün ilk yatış yeri palyatif bakımdı, bu hastalardan sadece 19’u tekrar yoğun bakıma sevk edildi. Palyatif servise yatışta yıllar içinde istatistiksel olarak anlamlı artış izlendi (p<0.001). Dış merkezlerden başvurunun seneler içinde istatistiksel olarak arttığı bulundu (p˂0.001). Hastalara uygulanan, non-invaziv mekanik ventilasyon, vazopressör tedavide yıllar içinde istatistiksel olarak anlamlı düşüş tespit edildi (p<0.001). Sonuç: Palyatif servislerin etkin olarak kullanıma başlanması yaşamın sonunda gereksiz agresif tedavilerin ve dolayısıyla maliyetin azalmasına ve yoğun bakım yataklarının etkin kullanımına da yol açacaktır. Ülke sağlık politikası belirlenmesine yardımcı olacak palyatif bakım farkındalığını arttırmaya yönelik çalışmalara ihtiyaç vardır.
- 1 January 2022
- Published by Kare Publishing in Eurasian Journal of Pulmonology
- Vol. 25 (1) , 39-45
Thirdhand smoke: How aware are patients?
Objective: The use of tobacco and tobacco products is one of the biggest public health problems that continue to threaten human health worldwide. Thirdhand smoke (THS) is a new concept that emerges from tobacco use, and there are not enough studies on its effects on human health. Therefore, we aimed to determine the level of awareness of THS and the parameters affecting it in individuals who applied to a chest disease hospital in Turkey. Materials and methods: 400 volunteers who admitted to our hospital between February and March 2022 were literate and accepted the study at the end of the briefing were included in the study. Volunteers were given a questionnaire including the demographic characteristics and Baths-T survey which was used to determine the awareness of THS. Results: Of 400 participants included in the study, 162 (40.5%) were female, 238 (59.5%) were male, and their mean age was 44.09±12.75 years. In our study, the mean Baths–T score was 35.1±6.74. The persistence and health beliefs mean score was 15.51±3.54, 19.58 ±3.74 respectively. It was determined that the total and two sub-dimension scores were statistically significantly higher in women than in men (p=0.019, 0.046, 0.011). Awareness was statistically significantly lower in smokers and those with low education levels (p=0.001,0.014). Conclusion: We think that the male gender, low education level, and smokers, whose awareness level is low, should be the primary target group in informing about THS.
- 1 January 2022
- Published by Kare Publishing in Eurasian Journal of Pulmonology
- Vol. 25 (1) , 39-45
Thirdhand smoke: How aware are patients?
Objective: The use of tobacco and tobacco products is one of the biggest public health problems that continue to threaten human health worldwide. Thirdhand smoke (THS) is a new concept that emerges from tobacco use, and there are not enough studies on its effects on human health. Therefore, we aimed to determine the level of awareness of THS and the parameters affecting it in individuals who applied to a chest disease hospital in Turkey. Materials and methods: 400 volunteers who admitted to our hospital between February and March 2022 were literate and accepted the study at the end of the briefing were included in the study. Volunteers were given a questionnaire including the demographic characteristics and Baths-T survey which was used to determine the awareness of THS. Results: Of 400 participants included in the study, 162 (40.5%) were female, 238 (59.5%) were male, and their mean age was 44.09±12.75 years. In our study, the mean Baths–T score was 35.1±6.74. The persistence and health beliefs mean score was 15.51±3.54, 19.58 ±3.74 respectively. It was determined that the total and two sub-dimension scores were statistically significantly higher in women than in men (p=0.019, 0.046, 0.011). Awareness was statistically significantly lower in smokers and those with low education levels (p=0.001,0.014). Conclusion: We think that the male gender, low education level, and smokers, whose awareness level is low, should be the primary target group in informing about THS.
- 1 September 2015
- Published by European Respiratory Society (ERS)
- Vol. 46 (suppl 59) , PA4311
General characteristics and therapeutic options in lung cancer in Turkey
ASPECT study, a prospective multicenter study conducted in Turkey with the participation of 26 centers, including all patients with lung cancer, who agreed to participate in the study, were re-evaluated in terms of demographic characteristics of patients (pts), disease characteristics, and the treatment options in lung cancer. Among 1245 cases (88.7% man) included, %83.4 had advanced stage (stage 3-4) lung cancer. Histopathologic types were squamous cell in 39.3%, adenocancer in 29.6%, SCLC in 19.0%, NSCLC in 10.2% and others. Of the pts, 45.5% had a comorbid disease, 49.3% had weight loss (at least 5% of body weight), and 31.6% had a history of cancer in family. PET-CT was used in 83.3% of the pts for diagnosis of staging. Metastasis was detected in 54.2% of pts (43.9% bone, 23.1% brain, %20.2% liver, 17.3% surrenal metastasis). Treatment options were chemotherapy in 45.9%, chemo-radiotherapy in 28.2%, and surgery in 18.4% of the pts. Chemotherapy was mostly platin based doubles including etoposide (14.9%), paclitaxel (14.0%), gemcitabine (12.3%), docetaxol (4.3%), pemetrexed (2.2%), vinorelbin (4.9%), and others. The use of targeted therapies was detected in 1.1% of the pts. Palliative radiotherapy was given in 21.1% of the pts (8.5% brain, 7.2% bone, 6.7% thorax, and others). Interventional bronchoscopy or bronchial stenting was performed in 2.0% and pleurodesis in 1.8%. Of the pts, 10.5% reported the use of herbal medicine products. Most pts with lung cancer presented in advanced stages and only 18.4% had a chance for surgery. Conventional chemotherapy and radiotherapy was the most common therapeutic options but the use of targeted therapies and interventional procedures seems to be quite low.
- 1 September 2015
- Published by European Respiratory Society (ERS)
- Vol. 46 (suppl 59) , PA4311
General characteristics and therapeutic options in lung cancer in Turkey
ASPECT study, a prospective multicenter study conducted in Turkey with the participation of 26 centers, including all patients with lung cancer, who agreed to participate in the study, were re-evaluated in terms of demographic characteristics of patients (pts), disease characteristics, and the treatment options in lung cancer. Among 1245 cases (88.7% man) included, %83.4 had advanced stage (stage 3-4) lung cancer. Histopathologic types were squamous cell in 39.3%, adenocancer in 29.6%, SCLC in 19.0%, NSCLC in 10.2% and others. Of the pts, 45.5% had a comorbid disease, 49.3% had weight loss (at least 5% of body weight), and 31.6% had a history of cancer in family. PET-CT was used in 83.3% of the pts for diagnosis of staging. Metastasis was detected in 54.2% of pts (43.9% bone, 23.1% brain, %20.2% liver, 17.3% surrenal metastasis). Treatment options were chemotherapy in 45.9%, chemo-radiotherapy in 28.2%, and surgery in 18.4% of the pts. Chemotherapy was mostly platin based doubles including etoposide (14.9%), paclitaxel (14.0%), gemcitabine (12.3%), docetaxol (4.3%), pemetrexed (2.2%), vinorelbin (4.9%), and others. The use of targeted therapies was detected in 1.1% of the pts. Palliative radiotherapy was given in 21.1% of the pts (8.5% brain, 7.2% bone, 6.7% thorax, and others). Interventional bronchoscopy or bronchial stenting was performed in 2.0% and pleurodesis in 1.8%. Of the pts, 10.5% reported the use of herbal medicine products. Most pts with lung cancer presented in advanced stages and only 18.4% had a chance for surgery. Conventional chemotherapy and radiotherapy was the most common therapeutic options but the use of targeted therapies and interventional procedures seems to be quite low.